Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
2021
112 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
11.73
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma | Researchclopedia
·
Columbia University
Kirsten B. Burdett
·
Northwestern University
Pavan S. Upadhyayula
·
Columbia University
Catalina Lee-Chang
·
Northwestern University
Joseph Shilati
·
Northwestern University
Dinesh Jaishankar
·
Northwestern University
Li Chen
·
Northwestern University
Andrew Gould
·
Northwestern University
Daniel Y. Zhang
·
Northwestern University
Jinzhou Yuan
·
Columbia University
Wenting Zhao
·
Columbia University
Xiaoyang Ling
·
The University of Texas MD Anderson Cancer Center
Jared K. Burks
·
The University of Texas MD Anderson Cancer Center
Brice Laffleur
·
Inserm
Christina Amidei
·
Northwestern University
Jeffrey N. Bruce
·
Columbia University
Rimas V. Lukas
·
Northwestern University
Jonathan T. Yamaguchi
·
Northwestern University
David Cieremans
·
Columbia University
Gerson Rothschild
·
Columbia University
Uttiya Basu
·
Columbia University
Matthew McCord
·
Northwestern University
Daniel J. Brat
·
Northwestern University
Hui Zhang
·
Northwestern University
Lee Cooper
·
Northwestern University
Bin Zhang
·
Northwestern University
Peter A. Sims
·
Columbia University
Tim Cloughesy
·
University of California, Los Angeles
Robert M. Prins
·
University of California, Los Angeles
Peter Canoll
·
Columbia University
Roger Stupp
·
Northwestern University
Amy B. Heimberger
·
Northwestern University
Craig Horbinski
·
Northwestern University
Fábio M. Iwamoto
·
Columbia University
Raúl Rabadán
·
Columbia University
Adam M. Sonabend
·
Northwestern University